Skip to menu Skip to content Skip to footer

Development of an IL-22 based immunocytokine as a novel therapeutic approach in type 2 diabetes (2018-2019)

Experts

Dr Sahar Keshvari

Honorary Research Fellow
Mater Research Institute-UQ
Faculty of Medicine
Sahar Keshvari
Sahar Keshvari